Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Matthew Katz, MD

Advertisement

Articles by Matthew Katz, MD

New chemotherapeutic approaches in superficial bladder cancer

ByGerald L. Andriole, MD,Matthew Katz, MD
September 1st 2009

An overview of new agents and device-assisted therapies being investigated to improve outcomes for patients with superficial bladder cancer.

Advertisement

Latest Updated Articles

  • New chemotherapeutic approaches in superficial bladder cancer
    New chemotherapeutic approaches in superficial bladder cancer

    September 1st 2009



Advertisement
Advertisement

Trending on Urology Times

1

UGN-501 enters phase 1 testing for recurrent non–muscle invasive bladder cancer

2

ESMO 2026 On Location - Why pCR is not the whole story in cisplatin-ineligible MIBC

3

Infertility care: Examining geographic gaps in access

4

Alicia Morgans, MD, discusses cognitive outcomes with darolutamide vs enzalutamide

5

2026 AUA North Central Section Meeting: Updates in high-risk NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us